Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma

NCT00525447 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: SGN-40
DRUG: lenalidomide
DRUG: dexamethasone

Sponsor

Seagen Inc.

Collaborators

[object Object]